US 11261447
Methods for inhibition of HAO1 (hydroxyacid oxidase 1 (glycolate oxidase)) gene expression
granted A61KA61K31/713A61K45/06
Quick answer
US patent 11261447 (Methods for inhibition of HAO1 (hydroxyacid oxidase 1 (glycolate oxidase)) gene expression) held by Alnylam Pharmaceuticals, Inc. expires Mon Feb 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Mar 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/713, A61K45/06, A61K47/549, A61K47/61